As the demand for COVID-19 diagnostic tests soar, the FDA guidelines around emergency-use authorization continue to shift. Discover what has changed and what that means to your FDA approval path in this 30-minute webinar.

  • FDA priorities
  • Paths to commercialization
  • Modifications for use in laboratories and POC
  • Post-authorization conditions
  • Links to resources
  • 5 key takeaways

About the speaker:

Experienced Regulatory Affairs professional with a demonstrated history of working in the biotechnology industry. Career has been focused on Medical Devices and IVDs. Strong regulatory professional with over 20 years of experience.

Jo-Ann F. Gonzales, RAC
Director IVD Regulatory & Quality Consulting

View the talk below.